The identification of a new series of growth inhibitors of Trypanosomacruzi, the causative agent of Chagas' disease, is described. In vitro screening of a subset of compounds from our in-house compound collection against the parasite led to the identification of hit compound 1 with low micromolar inhibition of T. cruzi growth. SAR exploration on the hit compound led to the identification of compounds
Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors
申请人:Istituto de Ricerche di Biologia Molecolare P. Angeletti SpA.
公开号:US08026265B2
公开(公告)日:2011-09-27
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts and tautomers thereof. Compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cellular proliferative diseases, including cancer. They are also useful for treating neurodegenerative diseases, mental retardation, schizophrenia, inflammatory diseases, restenosis, immune disorders, diabetes, cardiovascular disorders and asthma.
A general approach to homochiral α-amino substituted bromo-heteroaromatics suitable for two-dimensional rapid analogue synthesis
作者:Carsten Schultz-Fademrecht、Olaf Kinzel、István E. Markó、Tomas Pospisil、Silvia Pesci、Michael Rowley、Philip Jones
DOI:10.1016/j.tet.2009.08.013
日期:2009.11
An efficient and general synthesis of homochiral alpha-amino substituted bromo-heteroaromatics B using a diastereoselective 1,2-addition has been developed. The obtained heteroaromatic intermediates allow for a rapid two-dimensional exploration of a new series of histone deacetylase inhibitors, through Suzuki-Miyaura cross-coupling reactions for the introduction of a second aromatic element, followed by global deprotection and derivatization of the amino group. (C) 2009 Published by Elsevier Ltd.
HETEROCYCLE SUBSTITUTED KETONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS
申请人:ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P.
ANGELETTI S.P.A.